ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 233

Intensive CBT Is Effective in the Treatment of Significant Functional Impairment and Psychological Distress Found in Fibromyalgia: But Can We Improve Depressive Symptoms?

Barbara Bruce 1, Madeleine Allman 2, Jessica Gehin1, Loretta Oliphant 1, Fernando Rivera 1 and Andy Abril 1, 1Mayo Clinic, Jacksonville, FL, 2Baylor College of Medicine, Houston, TX

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: depression and cognitive behavioral therapy, fibromyalgia

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Fibromyalgia & Other Clinical Pain Syndromes Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The study was designed to evaluate the effectiveness and durability of an intensive cognitive behavioral intervention on functioning and depression in patients with Fibromyalgia (FM).  Despite significant statistical improvements observed in functional status and level of depression, high rates of depression remained at follow-up.  Analyses were designed to determine why depression rates remained high in order to identify more effective interventions

Methods: The patients included in the study were 141 adults with a diagnosis of FM who participated in an intensive two day treatment program for FM provided at a tertiary medical center. The Center for Epidemiologic Studies of Depression Scale (CES-D) and the FM Impact Questionnaire-Revised (FIQR) were completed at the time of admission to the 2-day structured FM Treatment Program and at 3 and 6 month follow-up. The FM Treatment Program is a cognitive behavioral treatment program that focuses upon strategies to decrease central sensitization including management tools to decrease pain, fatigue, assist with sleep disturbance and improve cognitive issues associated with FM.  Strategies of behavioral activation, exercise, sleep hygiene and cognitive strategies are integral aspects of the treatment program.

Results: Table 1 contains demographic information for the sample.  As seen, patients were majority (85.1%) female and the average age was 52.26 years. Table 2 shows statistically significant improvements (p< 0.001) in depression levels (CES-D) and functional status (FIQR) at both 3 and 6 month follow up. 79.4% of patients met the clinical threshold for depression at intake. Following intervention, 52.5% and 53.9% of patients met the clinical threshold for depression at 3 and 6 month follow-up, respectively. As in Table 2, there was a significant effect of treatment on each of the CES-D subscales (Negative Affect: p=.002, Positive Affect: p=.002, Somatic Symptoms: p< .0001, Interpersonal Distress: p=.019). Of 20 CES-D items, 14 were significantly improved by treatment (p< .05). 6 items did not change significantly after treatment: ‘I felt depressed,’ ‘I felt hopeful about the future,’ ‘I felt lonely,’ ‘People were unfriendly,’ ‘I enjoyed life,’ ‘I felt sad’ (p >.05) (Table 2). Three paired samples t-tests with Bonferroni corrections to make post hoc comparisons between time points for each significant effect (Table 3).

Conclusion: The intensive CBT treatment program was successful in improving functional impairment and psychological distress in a sample of Fibromyalgia patients.  The improvements were maintained at 6 month follow-up.  Despite statistically significant improvements in levels of depression, more than half of subjects continued to meet the clinical threshold for depression following CBT intervention. While CBT is regarded as the gold-standard treatment for depression in Fibromyalgia, some patients may require additional strategies for improvement. Factors important to address in this population to improve treatment effectiveness are contained in Table 2. 


Table 1

Table 1


Table 2.

Table 2


Table 3

Table 3


Disclosure: B. Bruce, None; M. Allman, None; J. Gehin, None; L. Oliphant, None; F. Rivera, None; A. Abril, None.

To cite this abstract in AMA style:

Bruce B, Allman M, Gehin J, Oliphant L, Rivera F, Abril A. Intensive CBT Is Effective in the Treatment of Significant Functional Impairment and Psychological Distress Found in Fibromyalgia: But Can We Improve Depressive Symptoms? [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/intensive-cbt-is-effective-in-the-treatment-of-significant-functional-impairment-and-psychological-distress-found-in-fibromyalgia-but-can-we-improve-depressive-symptoms/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/intensive-cbt-is-effective-in-the-treatment-of-significant-functional-impairment-and-psychological-distress-found-in-fibromyalgia-but-can-we-improve-depressive-symptoms/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology